Ge Healthcare Technologies Inc.
GE HealthCare Technologies Inc. Commences Debt Offering
Summary
On June 3, 2025, GE HealthCare Technologies Inc. commenced an underwritten offering of $650,000,000 aggregate principal amount of 4.800% Notes due January 15, 2031 and $850,000,000 aggregate principal amount of 5.500% Notes due June 15, 2035. The offering is expected to be issued on or around June 9, 2025, subject to customary closing conditions. The company entered into an Underwriting Agreement with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein.
Profitelligence Alerts
Get alerts for GEHC
Be first to know when Ge Healthcare Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Official SEC Documents
Advertisement